Literature DB >> 27884732

Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.

Minh-Trang Phan1, Sejong Chun2, Sun-Hee Kim2, Alaa Kassim Ali3, Seung-Hwan Lee3, Seokho Kim4, Soo-Hyun Kim5, Duck Cho6.   

Abstract

BACKGROUND: The purpose of this study was to identify CD56bright and CD56dim natural killer (NK) cell subsets and analyze their receptors expression in a healthy Korean population, and to determine whether receptor expression correlates with age, sex, and cytotoxicity.
MATERIALS AND METHODS: We performed multicolor flow cytometry assays to analyze the expression of various NK cell receptors (CD16, NKG2A, NKG2C, NKG2D, CD57, DNAM-1, CD8a, CD62L, NKp30, and NKp46) on both CD3-/CD56dim and CD3-/CD56bright NK cells in whole-blood samples from 122 healthy donors. The expression of these receptors was compared according to age (<30years, n=22, 30-60years, n=73 and >60years, n=27) and gender (male, n=61, female, n=61). NK cell cytotoxicity assays were performed with peripheral blood mononuclear cells (PBMCs) from 18 individuals. The results were compared to the expression levels of NKp30 and NKp46 receptors.
RESULTS: A normal reference range for NK cell receptor expression in two NK cell subsets was established. NKp46 and NKG2D expression gradually decreased with age (p<0.01 and p<0.05, respectively) whereas NK cell proportion and numbers, frequencies of CD56dim cells, and CD57 expression increased with age (p<0.01 in all cases). Men showed greater NK cell proportion and numbers, frequencies of CD56dim cells, and CD57 expression compared to those of women (p<0.05 and p<0.001; p<0.01 and p<0.01, respectively). Notably, the expression of NKp46 was negatively correlated with NK cell frequency (r=-0.42, p<0.001). Furthermore, NK cell cytotoxicity was found to positively correlate with NCR expression (p=0.02), but not NK cell proportion (p=0.80).
CONCLUSION: We have established a profile of NK cell surface receptors for a Korean population, and revealed that age and gender have an effect on the expression of NK cell receptors in the population. Our data might explain why neither NK cell numbers nor proportions correlate with NK cell cytotoxicity.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; NCR; NK cells; Receptor; Reference range; Subset

Mesh:

Substances:

Year:  2016        PMID: 27884732     DOI: 10.1016/j.humimm.2016.11.006

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

2.  Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population.

Authors:  Bo-Ram Kim; Sejong Chun; Duck Cho; Kyeong-Hee Kim
Journal:  J Clin Lab Anal       Date:  2018-08-13       Impact factor: 2.352

3.  Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study.

Authors:  Sue In Choi; Seung Hyeun Lee; Ji-Young Park; Kyoung-Ah Kim; Eun Joo Lee; Sang Yeub Lee; Kwang Ho In
Journal:  Onco Targets Ther       Date:  2019-02-27       Impact factor: 4.147

4.  Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation.

Authors:  Ki Hyun Park; Ji Hyeong Ryu; Hyunjoo Bae; Sojeong Yun; Joo Hee Jang; Kyungja Han; Byung Sik Cho; Hee-Je Kim; Hyeyoung Lee; Eun-Jee Oh
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

5.  Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.

Authors:  Sergi Pascual-Guardia; Michelle Ataya; Isabel Ramírez-Martínez; José Yélamos; Roberto Chalela; Salomé Bellido; Miguel López-Botet; Joaquim Gea
Journal:  Respir Res       Date:  2020-03-04

6.  Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain.

Authors:  Jae Joon Yoon; Ji A Song; Sue Youn Park; Jeong Il Choi
Journal:  Korean J Pain       Date:  2018-01-02

7.  Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.

Authors:  Peter J Darlington; Brandon Stopnicki; Tarik Touil; Jean-Sebastien Doucet; Lama Fawaz; Morgan E Roberts; Marie-Noëlle Boivin; Nathalie Arbour; Mark S Freedman; Harold L Atkins; Amit Bar-Or
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

8.  A Flow Cytometry-Based Whole Blood Natural Killer Cell Cytotoxicity Assay Using Overnight Cytokine Activation.

Authors:  Jinho Kim; Minh-Trang Thi Phan; SoonHo Kweon; HongBi Yu; Jeehun Park; Kyeong-Hee Kim; Ilwoong Hwang; Sangbin Han; Min-Jung Kwon; Duck Cho
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

9.  Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe.

Authors:  A Oras; B Quirant-Sanchez; D Popadic; S Thunberg; O Winqvist; S Heck; M Cwikowski; D Riemann; B Seliger; E Martinez Caceres; R Uibo; T Giese
Journal:  Clin Exp Immunol       Date:  2020-08-03       Impact factor: 4.330

10.  Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Yuzuru Sakamoto; Sachiyo Yoshio; Hiroyoshi Doi; Taizo Mori; Michitaka Matsuda; Hironari Kawai; Tomonari Shimagaki; Shiori Yoshikawa; Yoshihiko Aoki; Yosuke Osawa; Yuji Yoshida; Taeang Arai; Norio Itokawa; Masanori Atsukawa; Takanori Ito; Takashi Honda; Yoshihiro Mise; Yoshihiro Ono; Yu Takahashi; Akio Saiura; Akinobu Taketomi; Tatsuya Kanto
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.